Skip to main content
. 2015 Sep 28;26(12):2490–2495. doi: 10.1093/annonc/mdv473

Figure 1.

Figure 1.

(A) Kaplan–Meier estimates of the overall survival rate and progression-free survival (PFS) rate of 47 CTCL patients who underwent stem cell transplantation. (B) Kaplan–Meier estimates of PFS rates after stem cell transplantation in patients with mycosis fungoides (MF)/no transformation; mycosis fungoides/Sézary syndrome (MF/SS), mycosis fungoides/large-cell transformation (MF/LCT), and mycosis fungoides/Sézary syndrome/large-cell transformation (MF/SS/LCT).